Subscribe to RSS
DOI: 10.1055/s-0042-104508
Assessment of Pharmacological Treatment Quality: Comparison of Symptom-triggered vs. Fixed-schedule Alcohol Withdrawal in Clinical Practice
Publication History
received 23 December 2015
revised 25 February 2016
accepted 29 February 2016
Publication Date:
21 April 2016 (online)
Abstract
Introduction: Despite the fact, that symptom-triggered alcohol withdrawal treatment is recommended by German guidelines on alcoholism, many hospitals continue to use fixed-schedule protocols, as they have been successfully applied for many years.
Methods: This retrospective study compared all patients’ records of alcohol withdrawal treatment from October 2010 to November 2011 at Magdeburg’s University Department of Psychiatry (n=120). A symptom-triggered protocol with clomethiazole (AESB, n=46) was used in parallel with the existing fixed-schedule protocol with diazepam (n=74).
Results: The symptom-triggered group showed less need of pharmacological treatment duration (p<0.001) and cumulative dosage of medication compared to the fixed-schedule protocol (p<0.006). No difference was observed regarding the need of clonidine or haloperidol (to treat blood pressure derailment or delirium) and the incidence of epileptic seizures.
Discussion: Based on the shorter treatment duration and a similar rate of complications our department has switched to the symptom-triggered protocol to improve the quality of patient care.
* These authors contributed equally to this paper
Supporting Information
- for this article is available online at http://dx.doi.org/10.1055/s-0042-104508
- Supporting Information
-
References
- 1 Kraepelin E. Compendium der Psychiatrie. Leipzig: Ambr. Abel Verlag; 1883
- 2 Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs 2014; 401-410 DOI: 10.1007/s40263-014-0163-5.
- 3 Caputo F, Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des 2010; 16: 2118-2125
- 4 Manasco A, Chang S, Larriviere J et al. Alcohol withdrawal. South Med J 2012; 105: 607-612
- 5 Sullivan JT, Sykora K, Schneiderman J et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84: 1353-1357
- 6 Lange-Asschenfeldt C, Müller MJ, Szegedi A et al. Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis. Eur Addict Res 2003; 1-7 DOI: 10.1159/000067729.
- 7 Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. Berlin Heidelberg: Springer-Verlag; 2015
- 8 Cassidy EM, O’Sullivan I, Bradshaw P et al. Symptom-triggered benzodiazepine therapy for alcohol withdrawal syndrome in the emergency department: a comparison with the standard fixed dose benzodiazepine regimen. Emerg Med J 2012; 802-804 DOI: 10.1136/emermed-2011-200509.
- 9 Duby JJ, Berry AJ, Ghayyem P et al. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute Care Surg 2014; 938-943 DOI: 10.1097/TA.0000000000000352.
- 10 Sachdeva A, Chandra M, Deshpande SN. A comparative study of fixed tapering dose regimen versus symptom-triggered regimen of lorazepam for alcohol detoxification. Alcohol Alcohol 2014; 287-291 DOI: 10.1093/alcalc/agt181.
- 11 Daeppen J-B, Gache P, Landry U et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002; 162: 1117-1121
- 12 Mann K, Hoch E, Batra A. S3-Leitlinie, Screening, Diagnose und Behandlung alkoholbezogener Störungen. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Internet http://www.awmf.org/uploads/tx_szleitlinien/076-001l_S3-Leitlinie_Alkohol_2016-02.pdf last update: Feb. 28, 2016
- 13 Maldonado JR, Nguyen LH, Schader EM et al. Benzodiazepine loading versus symptom-triggered treatment of alcohol withdrawal: a prospective, randomized clinical trial. Gen Hosp Psychiatry. 2012: 611-617 DOI: 10.1016/j.genhosppsych 2012.06.016
- 14 Elholm B, Larsen K, Hornnes N et al. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. Alcohol Alcohol 2011; 318-323 DOI: 10.1093/alcalc/agr020.
- 15 Bianchi V, Premaschi S, Raspagni A et al. A comparison between serum carbohydrate-deficient transferrin and hair ethyl glucuronide in detecting chronic alcohol consumption in routine. Alcohol Alcohol 2015; 266-270 DOI: 10.1093/alcalc/agv005.
- 16 Bonnet U, Lensing M, Specka M et al. Comparison of two oral symptom-triggered pharmacological inpatient treatments of acute alcohol withdrawal: clomethiazole vs. clonazepam. Alcohol Alcohol 2010; 68-73 DOI: 10.1093/alcalc/agq081.
- 17 de Millas W, Ganzer F, Kuhn S et al. Oxazepam versus clomethiazol in alcohol withdrawal treatment. Eur Addict Res 2010; 179-184 DOI: 10.1159/000317246.
- 18 Murdoch J, Marsden JA. “symptom-triggered” approach to alcohol withdrawal management. Br J Nurs 2014; 198-202 DOI: 10.12968/bjon.2014.23.4.198.
- 19 Haring B, Kutschis M, Bleich S et al. The new reimbursement for psychiatry and psychosomatics – challenges, opportunities and risks of the new financing system. Fortschr Neurol Psychiatr 2014; 30-38 DOI: 10.1055/s-0033-1356344.
- 20 Vollmann J. The new financial compensation system PEPP: an ethical analysis. Nervenarzt 2014; 1410-1418 DOI: 10.1007/s00115-014-4019-5.
- 21 Jordan W, Bleich S, Cohrs S et al. Definition des Kernbereichs ärztlicher Tätigkeit im psychiatrisch-psychotherapeutischen Fachgebiet – Voraussetzung für jede Delegation. Psychiat Prax 2011; 8-15 DOI: 10.1055/s-0031-1276945.
- 22 Jordan W, Adler L, Bleich S et al. Ärztemangel im psychiatrischen Krankenhaus – Zukunftssicherung durch Neuordnung des ärztlichen Dienstes. Psychiat Prax 2011; 16-24 DOI: 10.1055/s-0031-1276946.